Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Benjamin Chukwurah
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
Observed institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
ORCID:
0009-0003-2197-8809
Observed ORCID:
0009-0003-2197-8809
OpenAlex ID:
A5107081592
FDA Approval Summary: Belzutifan for Patients with Advanced Renal Cell Carcinoma
2024
·
Jaleh Fallah
, Brian L. Heiss
, et al.
·
Clinical Cancer Research
·
38
Data from FDA Approval Summary: Belzutifan for Patients with Advanced Renal Cell Carcinoma
2024
·
Jaleh Fallah
, Brian L. Heiss
, et al.
Supplementary Table S1 from FDA Approval Summary: Belzutifan for Patients with Advanced Renal Cell Carcinoma
2024
·
Jaleh Fallah
, Brian L. Heiss
, et al.
Show more works
View as search
Works count:
3
Citation count:
38
H-index:
1
I10-index:
1
Year
Topic
Type